ArticleBiomedicines2022

Orphan GPR26 Counteracts Early Phases of Hyperglycemia-Mediated Monocyte Activation and Is Suppressed in Diabetic Patients.

Zahra Abedi Kichi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.